Pfizer Recalls Effexor XR Capsules Due to Foreign Tablet Contamination
Pfizer is recalling specific lots of Effexor XR 150 mg capsules because a foreign Tikosyn capsule was found in a bottle.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of 5 according to the rubric.
Plain-English summary
Pfizer US Pharmaceutical Group is recalling 49,847 bottles of Effexor XR (venlafaxine HCl) Extended-Release Capsules, 150 mg. The affected products are packaged in 30-count and 90-count Unit of Use bottles and were distributed nationwide and in Puerto Rico. The recall involves Lot V130142 (Expiration 10/15) and Lot V130140 (Expiration 10/15).
The recall was initiated after a pharmacist reported that a bottle of Effexor XR 150 mg capsules contained a single peach-colored capsule printed with "TKN250." This foreign capsule was identified as a Tikosyn (dofetilide) capsule. The presence of a different medication in the packaging poses a risk of accidental ingestion of the wrong drug.
Consumers with these specific lot numbers should stop using the product and contact their healthcare provider or pharmacist for instructions on how to dispose of the medication or obtain a replacement. The recall is classified as Class I by the FDA, indicating a reasonable probability that use of the product will cause serious adverse health consequences or death.
The recalled product
- Product
- Effexor XR (venlafaxine HCl) Extended-Release Capsules, 150 mg, packaged in a) 30-count Unit of Use bottles (NDC 0008-0836-21) UPC 3 0008-0836-21 7; b) 90-count Unit of Use bottles (NDC 0008-0836-22) UPC 3 0008-0836-22 4; Rx only, Distributed by Wyeth Pharmaceuticals Inc., A…
- Manufacturer
- Pfizer Us Pharmaceutical Group
- Category
- Drug — Prescription Medication
- Affected units
- 49,847
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: a) V130142
- Exp 10/15
- b) V130140
Distribution
Related recalls
Same manufacturer · Pfizer Us Pharmaceutical Group
See all →- HighPfizer Recalls Pristiq 50 mg Tablets Due to Foreign 100 mg Tablet
FDA (Drugs) · 2014-07-02
- LowPfizer Recalls Advil PM Caplets Due to Low Diphenhydramine Levels
FDA (Drugs) · 2014-03-26
- ModeratePfizer Recalls Aldactone Tablets Due to Unapproved Manufacturing Site
FDA (Drugs) · 2013-11-27
Same hazard · foreign object
See all →- ModerateMezzetta Golden Greek Peperoncini Recalled for Potential Mouse Contamination
FDA (Food) · 2026-10-14
- SevereUnited and Good & Gather Light Brown Sugar Recalled for Wheat Contamination
FDA (Food) · 2026-09-30
- SevereBaxter Recalls Dextrose Injection Bags Due to Stainless Steel Particulate Matter
FDA (Drugs) · 2026-09-16
- ModerateBionpharma Recalls Doxylamine Succinate Tablets Due to Foreign Material Presence
FDA (Drugs) · 2026-09-09
- SevereTeva Recalls Trazodone Hydrochloride Tablets Due to Foreign Material
FDA (Drugs) · 2026-09-09
Similar recalls
- ModeratePfizer Recalls Tikosyn Capsules Due to Foreign Object Contamination
FDA (Drugs) · 2014-04-30
- CriticalGreenstone Recalls Venlafaxine Capsules Due to Foreign Capsule Contamination
FDA (Drugs) · 2014-06-18
- HighPfizer Recalls Pristiq 50 mg Tablets Due to Foreign 100 mg Tablet
FDA (Drugs) · 2014-07-02
- ModeratePfizer Recalls Tikosyn Capsules Due to Potential Cracks or Breakage
FDA (Drugs) · 2014-12-17
- LowStat Rx USA Recalls Venlafaxine ER Due to Labeling Error
FDA (Drugs) · 2012-11-21
- LowBreckenridge Recalls Duloxetine Capsules Due to Foreign Omeprazole Capsule
FDA (Drugs) · 2015-11-18